Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

Hollywood Internship Program prepares UNC students for careers in entertainment
Every summer, a select group of UNC students trade Chapel Hill for Hollywood, diving headfirst into the entertainment industry through the University’s competitive and career-shaping...
Tue Jul 1, 2025

5 Chapel Hill restaurants that have stood the test of time
In a town where new restaurants come and go, a few places have managed to stick around for generations. The following five Chapel Hill staples...
Sat Jun 28, 2025

The Astonishingly Successful Presidency of UNC Alum James K. Polk
In 1845, James K. Polk, newly elected to the presidency by a whisker-thin margin, confided to his friend George Bancroft the four goals of his...
Sat Jun 28, 2025

UNC computer science department looks to the future as it celebrates 60th anniversary
The University of North Carolina’s highly-ranked Department of Computer Science celebrated its 60th anniversary, hosting events in April. The department continues to grow, hiring new...
Fri Jun 27, 2025